News

5 Inverse ETFs That Gained More Than 20% in April

  • The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.
    05/01/2024

Top Performing Leveraged/Inverse ETFs: 04/21/2024

  • These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
    04/23/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

The price of Direxion Daily S&P Biotech Bear 3X Shares (LABD) is 8.28 and it was updated on 2024-05-04 01:03:06.

Currently Direxion Daily S&P Biotech Bear 3X Shares (LABD) is in undervalued.

News
    
News

5 Best Inverse-Leveraged ETFs of Last Week

  • Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.
    Tue, Apr. 23, 2024

Top Performing Leveraged/Inverse ETFs: 04/07/2024

  • These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
    Tue, Apr. 09, 2024

Top Performing Leveraged/Inverse ETFs: 03/17/2024

  • These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
    Tue, Mar. 19, 2024

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street delivered a downbeat performance last week.
    Mon, Mar. 18, 2024

Early IPO Activity Could Spell Bullishness for Biotech Industry

  • Since the end of October 2023, the S&P 500 Biotechnology Select Industry Index jumped over 30%. It could maintain its upward trajectory given the early IPO activity in 2024 thus far.
    Fri, Jan. 26, 2024
SEC Filings
SEC Filings
More Headlines
News

LABD: An Absolute Avoid

  • Shorting and inverse bets don't work over time on average, making inverse funds like Direxion Daily S&P Biotech Bear 3X Shares ETF a big avoid. The LABD ETF is a triple-leveraged inverse ETF that focuses on the biotechnology sector and aims to profit from a decline in the value of the index it tracks. LABD is not suitable for long-term investment, incurs high costs, and experiences high volatility, making it a high-risk, high-reward investment.
  • 01/05/2024

Top Performing Leveraged/Inverse ETFs: 11/12/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 11/14/2023

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street delivered a decent performance last week.
  • 11/13/2023

5 Inverse ETFs That Gained More Than 25% in October

  • The U.S. stock market wrapped up October with losses, marking the third-straight monthly decline for the first time since the onset of the COVID pandemic in March 2020.
  • 11/01/2023

Top Performing Leveraged/Inverse ETFs: 10/29/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 10/31/2023

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street delivered a downbeat performance last week.
  • 10/30/2023

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street gave a mixed performance last week with the S&P 500 and the Nasdaq Composite eking out moderate gains while the Dow Jones and the Russell 2000 slumped.
  • 10/10/2023

LABU And LABD: Another Attractive Double-Short Pairs Trade

  • Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode over time due to their higher beta and inability to stay correlated over longer timeframes. The performance of the couple is dependent on the behavior of the underlying, with the short couple expected to lose value during strong trends.
  • 09/29/2023

Top Performing Leveraged/Inverse ETFs: 09/24/2023

  • These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 09/26/2023

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street delivered a downbeat show last week with the S&P 500 and Nasdaq logging worst weeks since March due to rising rate worries.
  • 09/26/2023

Top Performing Leveraged/Inverse ETFs: 09/10/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 09/12/2023

5 Inverse ETFs That Gained in Double Digits in August

  • August was dull for Wall Street, with all three major indices finishing in the red. This resulted in huge demand for inverse or inverse-leveraged ETFs as these fetch outsized returns on bearish sentiments in a short span.
  • 09/01/2023

Inverse ETFs Soar as Market Turns Sour

  • Wall Street has been caught in feeble trading in the past week, triggered by the U.S. credit rating downgrade and now bank downgrades. This has resulted in huge demand for inverse or inverse-leveraged ETFs.
  • 08/09/2023

Top Performing Leveraged/Inverse ETFs: 08/06/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 08/08/2023

LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided

  • Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don't foresee this fund generating positive growth in the near future, either. LABD has a high expense ratio, and its investments in derivatives enhance the chances of default. Its drift is also at its worst since the fund's inception. LABD is a short-term trading tool for seasoned traders who have a strategy with clear entry and exit signals, and have a strong understanding of leverage.
  • 07/21/2023

5 Factors Why Inverse ETFs May Rule in 2H23

  • As short-sellers increase their bets against U.S. equities amidst a booming S&P 500 Index, we delve into why inverse ETFs may come to dominate the latter half of 2023.
  • 06/22/2023

May MDA Breakout Stocks/ETFs Week 20 - 2023: High-Frequency Gainers To Give You An Edge

  • Two new Breakout Stocks for Week 20 with better than 10% short-term upside, ETF updates, and two Dow 30 Picks. Average cumulative returns for 2023 are +68.3% YTD. The negative MG Signal continues, but peak gains were in COIN +14.4% and TLRY +7.1%. The Active ETF portfolio continues with YTD gains at +14.2%.
  • 05/14/2023

Leveraged Biotech ETFs: Hold LABU, Sell LABD

  • SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, the 3X leveraged Biotech ETF, is rated as a HOLD.
  • 04/19/2023

Top Performing Leveraged/Inverse ETFs: 03/26/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 03/28/2023

5 Best Leveraged ETFs of Last Week

  • Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street.
  • 03/27/2023

MDA Breakout Stocks/ETFs Week 13 - March 2023: High-Frequency Gainers To Give You An Edge

  • Two new Breakout Stocks for Week 13 with better than 10% short-term upside and a Dow 30 Pick. Average cumulative returns for 2023 are +47.4% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +62.4%. Last week peak gains were RIOT +31.0%, SVM +15.9%, NVDA +6.3%.
  • 03/26/2023

ETF Winners From the Fed Meeting & Yellen's Testimony

  • Inverse ETFs surged yesterday despite the Fed's less-hawkish tone. Yellen's testimony probably have triggered the market selloffs.
  • 03/23/2023

MDA Breakout Stocks/ETFs Week 12 - March 2023: High-Frequency Gainers To Give You An Edge

  • Two new Breakout Stocks for Week 12 with better than 10% short-term upside with ETFs and a Dow 30 Pick. Average cumulative returns for 2023 are +37.3% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +65.7%. EGO peaked at +8.3% gains for members.
  • 03/19/2023

Top Performing Leveraged/Inverse ETFs: 03/12/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 03/14/2023

MDA Breakout Stocks/ETFs Week 11 - March 2023: High-Frequency Gainers To Give You An Edge

  • Two new Breakout Stocks for Week 11 with better than 10% short-term upside and Dow 30 Picks. Average cumulative returns for 2023 are +37.6% YTD. The Momentum Gauges® continued negative with bear funds in the Active ETF with over 17% gains this week. SUP peaked at +20.9% for members.
  • 03/12/2023

Top Performing Leveraged/Inverse ETFs: 02/26/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 02/28/2023

The Most Shorted ETFs

  • Retailers, corporate bonds and homebuilders are some areas investors are using ETFs to bet against.
  • 02/23/2023

5 Least-Hurt Biotech ETFs of the Last Week

  • Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
  • 02/15/2023

Top Performing Leveraged/Inverse ETFs: 02/12/2023

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 02/14/2023

Best Inverse/Leveraged ETF Areas of Last Week

  • Wall Street was downbeat last week. The S&P 500 and the Nasdaq recorded the worst week since December.
  • 02/13/2023

Best Leveraged ETFs of Last Week

  • Wall Street was downbeat last week, probably due to the relentless market forecasts of a looming recession and an uncertain Fed rate outlook.
  • 12/13/2022

Top Performing Leveraged/Inverse ETFs: 12/11/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 12/13/2022

Top Performing Leveraged/Inverse ETFs: 11/20/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 11/22/2022

5 Best Inverse/Leveraged ETFs of Last Week

  • Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.
  • 11/21/2022

The Sell Rating Of LABD Is Reaffirmed

  • Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology sector has done relatively well during the last four months; it is expected to continue trading sideways.
  • 11/03/2022

LABD: A Bad Bad Drift

  • Leveraged ETFs have a non-linear, unpredictable behavior. A drift dashboard with 22 of them.
  • 11/02/2022

Top Performing Leveraged/Inverse ETFs: 09/25/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 09/28/2022

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street was downbeat last week. Rising rate worries and recessionary fears were the key concerns.
  • 09/26/2022

Top Performing Leveraged/Inverse ETFs: 09/18/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 09/20/2022

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street was downbeat last week on rising rate worries and FedEx'
  • 09/19/2022

Inverse ETFs Rally on Stocks' Worst Drop Since June 2020

  • U.S. stocks crashed on Sep 13, following hotter-than-expected inflation data. This has led to a surge in inverse or inverse-leveraged ETFs.
  • 09/14/2022

Top Performing Leveraged/Inverse ETFs: 08/21/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 08/23/2022

Biotech Bounces in August as M&A Activity Increases

  • The biotech sector deflated, as most sectors did, in the first half of 2022. However, the sector is in the midst of a comeback as mergers and acquisitions rise, signaling increased activity.
  • 08/22/2022

Best Inverse/Leveraged ETFs of Last Week

  • Wall Street was moderately downbeat last week due to a rise in bond yields.
  • 08/22/2022

Leveraged Biotech ETFs: Buy LABU, Sell LABD

  • Starting with September 2021, LABU had a record sequence of nine consecutive months with negative returns. During the biotech downtrend from September 2021 to April 2022, LABD has returned 207%.
  • 07/08/2022

Stocks See Worst Day in 2 Years: Inverse ETFs Shine

  • The bearish sentiments have raised the appeal for inverse or inverse-leveraged ETFs as these fetch outsized returns on bearish sentiments in a short span.
  • 05/19/2022

Inverse ETFs Take Flight as Market Turns Sour

  • The market sell-off has resulted in higher demand for inverse or inverse-leveraged ETFs as these fetch outsized returns on bearish sentiments in a short span.
  • 05/06/2022

Top Performing Leveraged/Inverse ETFs: 05/01/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 05/03/2022

5 Best Inverse/Leveraged ETFs of Last Week

  • The likelihood of faster-than-expected monetary policy tightening by the Federal Reserve sent key Wall Street indexes falling.
  • 05/02/2022

5 Inverse ETFs That Are Up More Than 60% in April

  • April was the worst-ever month for Wall Street. The market sell-off has resulted in higher demand for inverse or inverse-leveraged ETFs as these fetch outsized returns on bearish sentiments in a short span.
  • 05/02/2022

Top Performing Leveraged/Inverse ETFs: 04/24/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 04/26/2022

5 Best Inverse/Leveraged ETFs of Last Week

  • Several inverse leveraged ETFs won last week. Most winners were the outcome of the rising rate trend.
  • 04/25/2022

Top Performing Leveraged/Inverse ETFs: 04/17/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 04/19/2022

5 Top-Performing Leveraged/Inverse ETFs of Q1

  • The appeal for leveraged and inverse-leveraged ETFs has increased as these fetch outsized returns on quick market turns in a short span.
  • 03/30/2022

CURE: One Of The Best Performing 3X Shares ETF

  • CURE: One Of The Best Performing 3X Shares ETF
  • 03/24/2022

LABD: 3X Leveraged Investments Not Suitable For Long Term

  • 3X inverse derivative investments are extremely volatile and risky.
  • 03/18/2022

5 Best Leveraged/Inverse ETFs at Halfway Q1

  • The appeal for leveraged and inverse-leveraged ETFs has increased as these have fetched outsized returns on quick market turns in a short span.
  • 02/22/2022

Leveraged/Inverse ETFs Up More Than 30% in January

  • The appeal for leveraged and inverse-leveraged ETFs increased as these fetched outsized returns on quick market turns in a short span.
  • 02/01/2022

Top Performing Leveraged/Inverse ETFs: 01/23/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 01/25/2022

Take a Look at Inverse ETFs Up More Than 50% YTD

  • Here we highlight some Inverse ETFs up more than 50% so far in 2022.
  • 01/25/2022

Top Performing Leveraged/Inverse ETFs: 01/09/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 01/12/2022

5 Best Inverse/Leveraged ETF Areas of Last Week

  • The latest Fed minutes came across as pretty hawkish, which spurred rising rate concerns in the United States.
  • 01/10/2022

Top Performing Leveraged/Inverse ETFs: 01/02/2022

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 01/05/2022

Top Performing Leveraged/Inverse ETFs: 12/05/2021

  • Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
  • 12/09/2021

5 Best Inverse-Leveraged ETFs of Last Week

  • Last week was downbeat for Wall Street? Apart from the Omicron woes, inflationary pressure continued to bother markets.
  • 12/06/2021

5 Leveraged/Inverse ETFs Up More Than 15% in November

  • The month of November proved to be volatile for the U.S. stock market given rising inflation, a surge in COVID-19 cases and Fed's taper talks.
  • 12/01/2021

This Bearish Biotech ETF Is up 16% in the Past Month

  • The biotech sector was one of the darlings amid the vaccine rally in 2020, but there's since been some bearishness, which is benefiting the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed 16% the past month, giving bearish biotech traders something to cheer about.
  • 10/12/2021

6 Top-Performing Leveraged/Inverse ETFs of September

  • September proved the historical trends to be true as Wall Street logged in the worst month of this year.
  • 10/01/2021

5 Inverse ETFs Jump Most on Market Sell-Off

  • We have highlighted the five best-leveraged inverse ETFs that piled up handsome gains on the broad sell-off.
  • 09/29/2021

6 Inverse ETFs Gain on Broad Market Sell-Off

  • The broad market sell-off has resulted in a spike for inverse or inverse leveraged ETFs. These products either create a short position or a leveraged short position in the underlying index.
  • 09/21/2021

September Lull Starts: Inverse ETFs Won Last Week

  • Wall Street witnessed a bloodbath last week, resulting in a solid run-up in inverse ETFs.
  • 09/13/2021

5 Top-Performing Leveraged/Inverse ETFs of July

  • While earnings optimism and a rebounding economy pushed the three major indices to new highs in July, concerns about the spread of the Delta variant of COVID-19 made investors jittery.
  • 08/02/2021

7 Inverse ETFs Riding High on Nasdaq Sell-Off

  • We have highlighted seven inverse ETFs that benefited the most from the Nasdaq sell-off.
  • 05/11/2021

Biotech Innovations Remain At Forefront

  • The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.
  • 04/16/2021

Moving Beyond COVID In Biopharma

  • Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those aged 65 years and older.
  • 04/15/2021

5 Inverse/Leveraged ETF Areas of Last Week

  • The last week was extremely upbeat for Wall Street with the S&P 500 and the Dow Jones at record highs.
  • 04/12/2021

7 Best Leveraged/Inverse ETFs Up 20% Plus in March

  • Amid the bull and bear tug-of-war, the demand for leveraged and inverse-leveraged ETFs has increased.
  • 03/31/2021

Top Inverse/Leveraged ETFs of Last Week

  • Last week was mixed for Wall Street. Tax hike fears, rising COVID-19 cases and still-existing rising rate worries led to the volatility.
  • 03/29/2021

Top 4 Inverse/Leveraged ETF Areas of Last Week

  • The first week of March was mixed for Wall Street. The energy sector has been the key winner.
  • 03/08/2021

Top 5 Leveraged ETFs of Last Week

  • Wall Street crashed last week with the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 losing about 2.5%, 1.8%, 4.9% and 2.4%, respectively.
  • 03/01/2021

Winning Leveraged ETFs of the Final Week of 2020

  • Wall Street saw a mixed performance last week probably because of rising COVID-19 cases globally while a stimulus deal cheered up the market.
  • 01/04/2021

SPXU Enters Positive Drift Regime

  • Leveraged ETFs sometimes have an unpredictable behavior. We illustrate our point with 22 ETFs tracking various indexes.
  • 09/02/2020

We Skipped The 3x Fangdango

  • Price movement is best explained by finite state theory as opposed to continuous time. These strategies are best suited for 401(k) accounts where there are no tax or record keeping issues.
  • 08/28/2020

Direxion Announces Reverse Splits of Six Daily Leveraged ETFs

  • Direxion has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily S&P Biotech Bear 3X Shares, Direxion Daily Semiconductor Bear 3X Shares, Direxion Daily Communication Services Index Bear 3X Shares, Direxion Daily Consumer Discretionary Bear 3X Shares, Direxion Daily Dow Jones Internet Bear 3X Shares, and the Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (each, a "Fund" and collectively, the "Funds"). The total market value of the shares outstanding will not be affected as a result of these splits, except with respect to the redemption of fractional shares, as outlined below.
  • 07/27/2020

SPXU: The Decay Has Worsened As Expected

  • Leveraged ETFs sometimes have an unpredictable behavior. We illustrate our point with 22 ETFs tracking various indexes. Then we focus on the behavior of SPXU.
  • 07/02/2020

The Reopening Killed The V-Shaped Recovery

  • This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
  • 06/29/2020

V&M Premium Portfolio: 2020 Mid-Year Report Card Through Week 26

  • The Premium Portfolio is up +14.43% YTD, while the benchmark S&P 500 Index is down -6.86% through June 26th. The Premium Portfolio has beaten the S&P 500 every
  • 06/29/2020

USO, UCO, LABU and ITB among weekly ETF movers

  • Gainers: Direxion Homebuild & Suppliers Bull 3X (NYSEARCA:NAIL) +32.00%.Direxion S&P Biotech Bear 3X (NYSEARCA:LABD) +19.7%.Latin America Bull 3X Direxion (NYSEARCA:LBJ) +18.7%.Microsectors U.
  • 05/01/2020

USO, OIL, TQQQ and SQQQ among weekly ETF movers

  • Gainers: DB Crude Oil -2X ETN Powershares (NYSEARCA:DTO) +81.4%.BMO Rex Microsectors Fang Index 3X Leveraged Ex (NYSEARCA:FNGU) +35.0%.Direxion S&P Biotech Bull 3X (NYSEARCA:LABU) +30.2%.Ultrashor
  • 04/18/2020

Week 16 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Revealing more about the Momentum Gauge model in a new section to help you use the best types of trades for the best returns during different cycles. Two sample
  • 04/13/2020

Amarin Corportion Plc: Now Compelling On Ex-U.S. Opportunity And Potential Barriers To Generic Competition

  • A U.S. District Court ruling found that Amarin’s patents for Vascepa were invalid due to obviousness; shares dropped 71%. Amarin will appeal; Some believe the d
  • 04/06/2020

Week 15 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Revealing more about the Momentum Gauge model in a new section to help you use the best types of trades for the best returns during different cycles. Two sample
  • 04/04/2020

The Worst Decay In SPXU's History

  • Leveraged ETFs sometimes have an unpredictable behavior. We illustrate our point with 20+ ETFs in various asset classes and stock indexes. Then we focus on the
  • 04/03/2020

Week 14 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 14 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +11.10% YTD compared to the S&P 500 -2
  • 03/28/2020

Revisiting The Signals That Forecasted Every Recent Decline, In Search Of Early Recovery Indicators

  • Members of my service were alerted on Feb. 24th of a negative Momentum Gauge signal that once again forecasted the correction ahead of another major downturn. T
  • 03/24/2020

Week 13 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 13 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +14.16% YTD compared to the S&P 500 -2
  • 03/21/2020

Week 12 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 12 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +11.60% YTD compared to the S&P 500 -1
  • 03/15/2020

Leveraged ETFs Decays: Warning Signal For SPXU

  • Why do leveraged ETFs drift? The best and the worst drifts. A warning signal for SPXU.
  • 03/10/2020

Week 11 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Four new Breakout Stocks for Week 11 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +37.51% YTD compared to the S&P 500 -8.0
  • 03/09/2020

Week 10 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • One sample Breakout Stocks for Week 10 with better-than-10% short-term upside potential and one sample Dow stock. The MDA Breakout portfolio is up +41.50% YTD c
  • 03/02/2020

Week 9 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • One sample Breakout Stocks for Week 9 with better-than-10% short-term upside potential and one sample Dow 30 stock pick. The MDA Breakout portfolio is up +36.11
  • 02/24/2020

Week 8 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Four new Breakout Stocks for Week 8 with better-than-10% short-term upside potential. The MDA Breakout portfolio is up +31.69% YTD compared to the S&P 500 up 4.
  • 02/17/2020

Will These Tech Stock Valuations Last?

  • Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to
  • 02/13/2020

3 Leveraged Healthcare ETFs Soaring This Month

  • Here are some geared healthcare ETFs that are enjoying fabulous February and may have more in store over the next couple of weeks.
  • 02/11/2020

3 Leveraged Healthcare ETFs Soaring This Month

  • The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic. ...
  • 02/10/2020

Should Investors Avoid U.S. Healthcare Stocks In An Election Year?

  • US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
  • 02/10/2020

Week 7 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 7 with better than 10% short-term upside potential and one sample Dow 30 stock pick. The streak of weekly selections gaining
  • 02/10/2020

VXX, UVXY and TVIX among weekly ETF movers

  • Gainers: Direxion S&P Biotech Bull 3X (NYSEARCA:LABU) +21%.Ultrapro Biotechnology Proshares (NASDAQ:UBIO) +21%.BMO Rex Microsectors Fang Index 3X Leveraged Ex (NYSEARCA:FNGU) +21%.Direxion South K
  • 02/07/2020

Leveraged ETFs: Drift Dashboard

  • Why do leveraged ETFs drift? Our drift watch list. The best and the worst drifts. Pros and cons of hedging with SPXU.
  • 02/04/2020

Week 6 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 4 with better than 10% short-term upside potential and one sample Dow 30 stock pick. The streak of weekly selections gaining
  • 02/02/2020

We Very Likely Have Seen An Equity Market Peak As Biotech, Junk Fall Along With Bond Yields

  • Several impressive price developments conclude that market peaks have been seen. First was PAM member jdefp's EWP measurement of ESc1=3338.38 as 161.8 Fibonacci
  • 01/26/2020

Week 5 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 4 with better than 10% short-term upside potential and one sample Dow 30 stock pick. The streak of weekly selections gaining
  • 01/25/2020

Week 4 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 4 with better than 10% short-term upside potential and one sample Dow 30 stock pick. The streak of weekly selections gaining
  • 01/18/2020

EQRx's Challenge, And My Challenge To Them

  • EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance
  • 01/16/2020

Week 3 MDA Breakout Forecast: Short-Term Picks To Give You An Edge

  • Two sample Breakout Stocks for Week 3 with better than 10% short-term upside potential and one sample Dow 30 stock pick. The streak of weekly selections gaining
  • 01/11/2020

Biotech Bonanza: 2020 Outlook In An Election Year

  • Biotechs closed out 2019 on a strong note, with the fourth quarter providing the longest sustained rally of the entire year. Favorable regulatory shifting, a ti
  • 01/08/2020

6 Best Leveraged Inverse ETFs of Past Week

  • We have highlighted six leveraged inverse ETFs that are up more than 15% over the past week.
  • 10/09/2019

Weekly ETF Gainers / Losers (04/26/19)

  • No summary available.
  • 04/26/2019
Unlock
LABD Ratings Summary
LABD Quant Ranking